Vienna-based PIUR IMAGING, a medical device company specializing in AI-powered tomographic 3D ultrasound, today announced a €5.6 million growth capital funding round. Aescuvest Capital Partners led this investment.
The company, founded in 2014, holds ISO-13485 certification and FDA clearance. Its proprietary sensor transforms standard 2D ultrasound systems into high-performance 3D imaging platforms. Consequently, clinicians can capture entire organs and anatomical structures in a single scan. Furthermore, AI-based image analysis enhances diagnostic accuracy and reproducibility across various clinical applications.
Fueling Global Commercial Expansion
This new PIUR IMAGING funding will primarily fuel commercial expansion, particularly within the United States. Following recent FDA clearance and the establishment of a U.S. subsidiary, the company is well-positioned for growth. Growth will focus on two core products: PIUR tUS Infinity, a vendor-neutral add-on, and PIUR tUS inside, an integrated solution for select GE HealthCare LOGIQ scanners.
The investment also supports expanding product integration with global ultrasound leaders, including companies like Siemens Healthineers and Philips Healthcare. Additionally, funds will advance the development of new clinical applications. This strategic move aims to improve patient outcomes and enhance diagnostic workflows. The company’s approach offers a transformative answer as healthcare systems seek to improve diagnostic access and efficiency.
